HomeMarkets Markets UBS: Lilly’s Type 2 diabetes and obesity treatment could be ‘one of the best-selling drugs in history’ By news September 22, 2022 0 132 FacebookTwitterPinterestWhatsApp Shares of Eli Lilly & Co. Inc. LLY,+4.89% gained 2.5% in premarket trading on Thursday after UBS upgraded the stock to buy from neutral, saying …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,493FansLike396,312FollowersFollow2,320SubscribersSubscribe Latest Articles Markets AI is already taking jobs, research shows. Routine tasks are the first to go Climate Saltwater flooding is a serious fire threat for EVs and other devices with lithium-ion batteries Markets ‘We Are Reeling’: Trump’s Pick of Tulsi Gabbard Alarms Intelligence Community Markets Populist podcasters love RFK, Jr., and he took the same left-right turn toward Trump as they did Markets Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary Markets Fallback Friday – Powell’s Caution Sends Futures Lower Charts PSW’s Weekly Webinar: Portfolio Review Climate We passed 1.5°C of human-caused warming this year (just not as the Paris agreement measures it) Markets The shift to global reshoring is already happening Markets How the stock market could perform under a unified GOP government Markets Marco Rubio: Trump’s foreign policy pick might be a hopeful sign for Nato Markets Friday essay: it’s ‘the intelligence age’, say tech titans – but information will not save us Markets Trump Officially Gives RFK Jr. Chance to Destroy Country’s Health Markets Senate Republicans squirm over Trump’s tariff plans Load more